Better Chemotherapy Regimens

Using our high-throughput screening methods, we are also testing the synergistic potential of FDA-approved cancer drugs as a smarter approach to treat certain forms of the disease. The hope of this study is that by using them together we can reduce the toxicity of the anti-cancer agents while at the same time increasing their overall effect on cancer cell growth.

Enzyme Replacement Therapy for Sanfilippo D

We are currently collaborating with Phoenix Nest, Inc. to develop a novel enzyme replacement therapy (ERT) for Mucopolysaccharidosis III D (MPS IIID), better known as Sanfilippo Syndrome.